The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Anlotinib in chemotherapy-refractory metastatic esophageal squamous cell carcinoma (ESCC): A randomized, double-blind, multicenter phase II trial.
 
Jing Huang
No Relationships to Disclose
 
Juxiang Xiao
No Relationships to Disclose
 
Wentao Fang
No Relationships to Disclose
 
Ping Lu
No Relationships to Disclose
 
Qingxia Fan
No Relationships to Disclose
 
Yongqian Shu
No Relationships to Disclose
 
Ji Feng Feng
No Relationships to Disclose
 
Shu Zhang
No Relationships to Disclose
 
Yi Ba
No Relationships to Disclose
 
Ying Liu
No Relationships to Disclose
 
Chunmei Bai
No Relationships to Disclose
 
Yu-Xian Bai
No Relationships to Disclose
 
Yong Tang
No Relationships to Disclose
 
Yan Song
No Relationships to Disclose
 
Jie He
No Relationships to Disclose